A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder

NCT01977378 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Sustained-Release Desvenlafaxine Hydrochloride
DRUG: Sustained-Release Venlafaxine Hydrochloride

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.